Prof. Lidia Rudnicka | |
---|---|
Born | |
Nationality | Poland, United States |
Awards | |
Academic background | |
Alma mater | Medical University of Warsaw |
Thesis | (1990) |
Academic work | |
Discipline | Dermatology |
Sub-discipline | Trichoscopy,Alopecia,Scleroderma |
Website | lidiarudnicka.pl |
Lidia Rudnicka (born February 19,1960 in Chicago,Illinois) is a Polish-American dermatologist with contributions to the field of scleroderma research,hair diseases and melanoma prevention. [1] [2] [ self-published source? ] [3] [ self-published source? ]
Rudnicka was the chairman of the Department of Dermatology CSK MSWiA (Central Clinical Hospital of Ministry of Internal Affaires) in Warsaw,Poland (1998–2014). [4] She is currently (starting 2014) chairman of the Department of Dermatology at Medical University of Warsaw. She is president of the Polish Dermatological Society,first president of the International Society of Trichoscopy,regional editor for the International Journal of Trichology,and associate editor of the Journal of the European Academy of Dermatology and Venereology. From 1990 to 1993,she worked in American and European institutions:Food and Drug Administration (USA),University of Liège (Belgium) and Thomas Jefferson University in Philadelphia (USA). [1] [2]
Additionally,Rudnicka has authored or co-authored over 200 articles and book chapters,mainly concerning autoimmune skin diseases,biological therapies,videodermoscopy,trichoscopy,epidemiology of skin diseases and managing medical institutions. [2]
Rudnicka graduated from Warsaw Medical School (having previously studied in Bonn and Cologne) in 1986. She went on to receive PhD in medical sciences in 1990 and habilitation degree in 1994. From 1987 to 1998 she worked as an Assistant Lecturer and Assistant Professor in Department of Dermatology,Warsaw Medical School. In 2001 she became Full Professor in medical sciencesSince 2008 Rudnicka has been professor at the Faculty of Health Sciences in Medical University of Warsaw. [1]
Rudnicka started her professional career in 1986 in Department of Immunopathology of National Institute of Hygiene. In 1987 she became Assistant Lecturer in Department of Dermatology,Warsaw Medical University. In 1986,she became chairman of the Department of Dermatology,CSK MSWiA (1998–2014). From 1990 to 1993 she worked in American and European institutions:Food and Drug Administration (National Institute of Health;1990),University of Liège (research laboratory of Department of Dermatology;1991) and Thomas Jefferson University,Philadelphia (Department of Dermatology;1991–1993). Since 2007 Rudnicka has been a member of National Examinary Commission for dermatology and venerology exams. In 2014 she was appointed chairman of the Department of Dermatology at Medical University of Warsaw. She participated in works of Institute of Clinical and Experimental Medicine,Polish Academy of Sciences. [1] [2]
Rudnicka's early work was related to the role of Natural Killer Cells and adhesion molecules in systemic sclerosis (scleroderma) and showed that activated peripheral blood mononuclear cells of scleroderma patients exhibit increased adhesion to vascular endothelial cells,which is an early event,preceding formation of perivascular lymphocytic infiltrates and development of skin fibrosis. [5]
She is the author of the hypothesis linking etiology of systemic sclerosis to a mutation in the topoisomerase I gene and abnormal topoisomerase I expression. She believes that presence of anti-topoisomerse I antibodies in sera of patients with scleroderma represents a protective reaction to these abnormalities. This hypothesis was partly confirmed by her studies. [6] [7] [8] [9] [10] [11] The study on which Urszula Nowicka's doctoral thesis was based showed a mutation in the 3’coding region of the topoisomerase gene in 56% of patients with anti-topo I –positive (Scl70-positive) systemic sclerosis. [8] It was also indicated that specific antibodies penetrate into the nuclei of fibroblasts and inhibit the activity of topoisomerase I. Moreover,the studies evidenced that topoisomerase I inhibitor,camptothecin,down-regulates the expression of type I collagen in fibroblasts of scleroderma patients and yields immunosuppressive effects. [6] [7] [9] [10] Certain cytokines were shown to increase the activity of topoisomerase I in dermal. [12]
The hypothesis by Rudnicka was discussed during medical conferences,but was never confirmed by other researchers. However,the findings related to the role of camptothecin and its potential therapeutical use were reaffirmed in the study by Zhang et al. conducted in patients with keloid. [13]
Another observation by Rudnicka and her co-workers,which may be potentially beneficial as far as managing systemic sclerosis is concerned,was abnormally high expression of prolactin in peripheral mononuclear cells obtained from patients. [14]
A second field of research of Rudnicka is related to hair and scalp disorders. She made a major contribution to development of hair and scalp dermoscopy (trichoscopy) and was the first to coin the term trichoscopy. Her and her co-workers’studies on genetic hair disorders showed that it is possible to diagnose genetic hair shaft abnormalities in children without the need of pulling hairs for microscopic evaluation. In 2005,Rudnicka and Malgorzata Olszewska used videodermatoscopy in assessing disease severity and monitoring impact of dutasteride therapy on hair thickness and hair shaft heterogeneity in androgenic alopecia,indicating this method can be used as a research tool to evaluate the effects of therapeutic or cosmetic agents [15] The next year,together with Malgorzata Olszewska and their co-workers she introduced the term trichoscopy for hair,scalp,eyebrows and eyelashes dermoscopy (videodermoscopy). [16] Their subsequent studies showed this technique can easily replace traditional microscopic evaluation in genetic hair shaft abnormalities such as Netherton syndrome,monilethrix,wooly hair syndrome,pili torti,pili annulati and trichothiodystrophy. [17] [18] [19] [20] It has also been proved trichoscopy can be useful in diagnosing acquired hair diseases including androgenic alopecia,alopecia areata,cicatrical alopecia and tinea. [20] [21]
Rudnicka and her co-workers were the first to apply in vivo confocal laser scanning microscopy in hair diagnostics. Their studies showed potential usefulness of this method in evaluation of hair shaft diseases. [22]
Lidia Rudnicka,together with Malgorzata Olszewska and Adriana Rakowska,has written the first Atlas of Trichoscopy,which was translated to multiple languages,including Chinese,Russian,Portuguese and Polish [23] and is considered by some dermatologists the main trichoscopy textbook.
Rudnicka is the organizer of a Polish nationwide campaign to promote prevention and early detection of melanoma (with dermoscopy and videodermoscopy). The campaign "Stop-Melanoma",based on highly successful Australian experience,is an ongoing program which started in 2004. [24]
Clinical observations made by Rudnicka and her co-workers indicate the rationality of long-term low-dose antibiotic therapy in chronic inflammatory skin diseases:SLE and psoriasis. [25] [26]
In 2014 Rudnicka was elected the president of the Polish Dermatological Society. She served as secretary of the board of this society in the years 2004–2008. Since 2004 she has been a member of board of International Dermoscopy Society. Rudnicka was a member of International Committee of American Academy of Dermatology in the term 2008–2012,she served as member and then chairman of the Poster Exhibition Task Force (2012–2018). She was one of the co-initiators to transform the Task Force into a Work Group (in 2017) to include a higher number of experts in the poster evaluation process. In 2017 Rudnicka was one of the four founding members of the International Trichoscopy Society,together with Antonella Tosti,Rodrigo Pirmez and Daniel Asz Sigall. She was elected first president of the International Trichoscopy Society.
Rudnicka was invited speaker and / or plenary speaker at multiple dermatology meetings,including:American Academy of Dermatology,European Academy of Dermatology and Venerology,(topics included:hair diseases,dermoscopy and skin cancer detection,psoriasis,psoriatic arthritis,biological therapy in skin diseases,connective tissue diseases,acne,clinical trials). [1] [2]
Lidia Rudnicka is honorary member of several medical societies,including the Russian Hair Research Society,Ukrainian Hair Research Society,and Mexican Hair Research Society.
Rudnicka is author or co-author of more than 200 articles and book chapters,mainly concerning autoimmune skin diseases,biological therapies,videodermoscopy,trichoscopy,epidemiology of skin diseases and managing medical institutions.
Rudnicka is managing editor of "Journal of Case Reports in Dermatology",former chairman of scientific board of "Dermatologica",associate editor of "Journal of the European Academy of Dermatology and Venereology",member of scientific and editorial boards of Journal of Drugs in Dermatology,Przeglad Dermatologiczny,and Dermatologia Estetyczna. She also reviews papers for significant periodicals in the field of dermatology and venerology,with Archives of Dermatology,Journal of European Academy of Dermatology and Venereology,Journal of Drugs in Dermatology,Expert Review in Dermatology among them. [1] [2]
Systemic scleroderma, or systemic sclerosis, is an autoimmune rheumatic disease characterised by excessive production and accumulation of collagen, called fibrosis, in the skin and internal organs and by injuries to small arteries. There are two major subgroups of systemic sclerosis based on the extent of skin involvement: limited and diffuse. The limited form affects areas below, but not above, the elbows and knees with or without involvement of the face. The diffuse form also affects the skin above the elbows and knees and can also spread to the torso. Visceral organs, including the kidneys, heart, lungs, and gastrointestinal tract can also be affected by the fibrotic process. Prognosis is determined by the form of the disease and the extent of visceral involvement. Patients with limited systemic sclerosis have a better prognosis than those with the diffuse form. Death is most often caused by lung, heart, and kidney involvement. The risk of cancer is increased slightly.
Alopecia areata, also known as spot baldness, is a condition in which hair is lost from some or all areas of the body. Often, it results in a few bald spots on the scalp, each about the size of a coin. Psychological stress and illness are possible factors in bringing on alopecia areata in individuals at risk, but in most cases there is no obvious trigger. People are generally otherwise healthy. In a few cases, all the hair on the scalp is lost, or all body hair is lost. Hair loss can be permanent, or temporary. It is distinct from pattern hair loss, which is common among males.
Hair loss, also known as alopecia or baldness, refers to a loss of hair from part of the head or body. Typically at least the head is involved. The severity of hair loss can vary from a small area to the entire body. Inflammation or scarring is not usually present. Hair loss in some people causes psychological distress.
Telogen effluvium is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair in the telogen phase. It is in this phase that telogen hairs begin to shed at an increased rate, where normally the approximate rate of hair loss is 125 hairs per day.
Alopecia universalis(AU), also known as alopecia areata universalis, is a medical condition involving the loss of all body hair, including eyebrows, eyelashes, chest hair, armpit hair, and pubic hair. It is the most severe form of alopecia areata. People with the disease are usually healthy and have no other symptoms and a normal life expectancy.
Tinea capitis is a cutaneous fungal infection (dermatophytosis) of the scalp. The disease is primarily caused by dermatophytes in the genera Trichophyton and Microsporum that invade the hair shaft. The clinical presentation is typically single or multiple patches of hair loss, sometimes with a 'black dot' pattern, that may be accompanied by inflammation, scaling, pustules, and itching. Uncommon in adults, tinea capitis is predominantly seen in pre-pubertal children, more often boys than girls.
The management of hair loss, includes prevention and treatment of alopecia, baldness, and hair thinning, and regrowth of hair.
Dermatoscopy also known as dermoscopy or epiluminescence microscopy, is the examination of skin lesions with a dermatoscope. It is a tool similar to a camera to allow for inspection of skin lesions unobstructed by skin surface reflections. The dermatoscope consists of a magnifier, a light source, a transparent plate and sometimes a liquid medium between the instrument and the skin. Dermatoscope is often handheld, although there are stationary cameras allowing the capture of whole body images in a single shot. When the images or video clips are digitally captured or processed, the instrument can be referred to as a digital epiluminescence dermatoscope. The image is then analyzed automatically and given a score indicating how dangerous it is. This technique is useful to dermatologists and skin cancer practitioners in distinguishing benign from malignant (cancerous) lesions, especially in the diagnosis of melanoma.
Morphea is a form of scleroderma that involves isolated patches of hardened skin on the face, hands, and feet, or anywhere else on the body, with no internal organ involvement.
Monilethrix is a rare autosomal dominant hair disease that results in short, fragile, broken hair that appears beaded. It comes from the Latin word for necklace (monile) and the Greek word for hair (thrix). Hair becomes brittle, and breaks off at the thinner parts between the beads. It appears as a thinning or baldness of hair and was first described in 1897 by Walter Smith
HLA-DR16(DR16) is a HLA-DR serotype that recognizes the DRB1*1601, *1602 and *1604 gene products. DR16 is found in the Mediterranean at modest frequencies. DR16 is part of the older HLA-DR2 serotype group which also contains the similar HLA-DR15 antigens.
HLA-DR5 (DR5) is a broad-antigen serotype that is further split into HLA-DR11 and HLA-DR12 antigen serotypes.
Anti-topoisomerase antibodies (ATA) are autoantibodies directed against topoisomerase and found in several diseases, most importantly scleroderma. Diseases with ATA are autoimmune disease because they react with self-proteins. They are also referred to as anti-DNA topoisomerase I antibody.
Scarring hair loss, also known as cicatricial alopecia, is the loss of hair which is accompanied with scarring. This is in contrast to non scarring hair loss.
Central centrifugal cicatricial alopecia (CCCA), is a type of alopecia first noticed in African Americans in the 1950s and reported by LoPresti et al. in 1968 as a result of application of petrolatum followed by a stove-heated iron comb. The original theory was that the hot petrolatum would travel down to the hair root, burn the follicle, and after repetitive injury scarring would result. Later CCCA was realized to affect men and women without a history significant for use of such styling techniques. Consequently, the terms "follicular degeneration syndrome" per Sperling and Sau in 1992 and then CCCA per Olsent et al. in 2003 were evolved. Plausible contributing factors may include other African-American styling techniques such as relaxers, tight braids, heavy extensions, certain oils, gels or pomades.
Pityriasis amiantacea is an eczematous condition of the scalp in which thick tenaciously adherent scale infiltrates and surrounds the base of a group of scalp hairs. It does not result in scarring or alopecia.
Trichoscopy is a method of hair and scalp evaluation and is used for diagnosing hair and scalp diseases. The method is based on dermoscopy. In trichoscopy hair and scalp structures may be visualized at many-fold magnification. Currently magnifications ranging from 10-fold to 70-fold are most popular in research and clinical practice.
Antonella Tosti is an Italian physician and scientist with major contributions in the field of dermatology, including developing dermoscopy for the diagnosis and care of hair diseases. Her contributions to knowledge about nails include research about videodermoscopy of the hyponychium and the nail plate.
Scleroderma is a group of autoimmune diseases that may result in changes to the skin, blood vessels, muscles, and internal organs. The disease can be either localized to the skin or involve other organs, as well. Symptoms may include areas of thickened skin, stiffness, feeling tired, and poor blood flow to the fingers or toes with cold exposure. One form of the condition, known as CREST syndrome, classically results in calcium deposits, Raynaud's syndrome, esophageal problems, thickening of the skin of the fingers and toes, and areas of small, dilated blood vessels.
Frontal fibrosing alopecia is the frontotemporal hairline recession and eyebrow loss in postmenopausal women that is associated with perifollicular erythema, especially along the hairline. It is considered to be a clinical variant of lichen planopilaris.